Sunday, 19 May 2013

News

Chinese genetics group defends US bid

27 Nov 2012 13:09

Financial Times

If the transaction is cleared, it will represent an opportunity for BGI-Shenzhen, China's leading genetic research company, to make significant inroads into the US market.

continue reading on Financial Times

Home
|
News
|
Markets
|
My FinData
|
Portfolio
|
Contact
|
RSS Feeds

Site Map
|
About FinData
|
Feedback
|
Advertise Online With Us
|
Terms of Use
|
Privacy Policy
|
Hosted by SPIDER

2013 © FinData Limited. All the material on this page has the protection of international copyright. All rights reserved.
NZX Quotes are delayed at least 20 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice.
FinData will not be liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.
By accessing the FinData site, you agree not to redistribute the information found therein.